[Federal Register Volume 76, Number 64 (Monday, April 4, 2011)]
[Notices]
[Pages 18554-18555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-7886]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-11-11DT]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960 or
send comments to Daniel Holcomb, CDC Reports Clearance Officer, 1600
Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to
[email protected].
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Monitoring Outcomes of the Enhanced Comprehensive HIV Prevention
Planning (ECHPP) Project-New-National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The scope of the HIV epidemic in the United States is significant,
particularly in large urban areas where HIV/AIDS cases are
concentrated. In 2006, approximately 56,000 new HIV infections occurred
in the U.S., demonstrating the need to expand targeted HIV prevention
efforts. In 2010, twelve U.S. metropolitan statistical areas (MSAs)
received funding, through their city and state health departments, to
conduct the Enhanced Comprehensive HIV Prevention Planning (ECHPP)
project. These twelve MSAs (Atlanta, GA; Baltimore, MD; Chicago, IL;
Dallas, TX; District of Columbia; Houston, TX; Los Angeles, CA; Miami,
FL; New York City, NY; Philadelphia, PA; San Francisco, CA; and San
Juan, PR) had the highest AIDS prevalence rates in the U.S. at the end
of 2007, representing 44% of all U.S. AIDS cases. The purpose of ECHPP
is to enhance existing HIV prevention services in these high prevalence
areas and provide an optimal mix of evidence-based behavioral,
biomedical, and structural interventions to have maximum impact on the
HIV/AIDS epidemic at the community level. ECHPP goals are consistent
with CDC's Division of HIV/AIDS Prevention Strategic Plan for HIV
Prevention and with the National HIV/AIDS Strategy: (1) Prevent new HIV
infections, (2) increase linkage to, and impact of, prevention and care
services for HIV-positive individuals, and (3) reduce HIV-related
health disparities.
To evaluate ECHPP, data will be collected through both existing CDC
data sources and through new data collection activities. Existing CDC
data sources will include HIV surveillance systems (e.g., National HIV
Behavioral Surveillance System, Medical Monitoring Project) that
routinely collect information about behavioral and clinical outcomes
from at-risk target populations in the 12 MSAs. A new data collection
activity is proposed through this project to collect information about
behavioral and clinical outcomes from injection drug users, high-risk
heterosexuals, and HIV-positive individuals who access medical care in
six of the 12 ECHPP-funded MSAs. These MSAs are: District of Columbia;
Houston, TX; Los Angeles, CA; Miami, FL; New York City, NY; and San
Francisco, CA. The purpose of this new data collection activity is to
monitor community-level outcomes of ECHPP and supplement HIV
surveillance data routinely collected in these areas. Outcome data will
be collected in these MSAs at two time points from 2011 to 2014.
Two surveys will be used in this project: (1) A community-based
survey to be administered to injection drug users and high-risk
heterosexuals, and (2) a clinic-based survey to be administered to HIV-
positive individuals seeking care at clinics that provide HIV-related
services. Both surveys will collect data on demographics, sexual
behavior, alcohol and drug use history, HIV testing experiences,
exposure to HIV prevention messages, and participation in HIV
prevention activities. The clinic survey will also include questions
about HIV treatment, treatment adherence, sources of care, and medical
outcomes. For the community survey, we intend to recruit and screen
1500 injection drug users and 1500 high-risk heterosexuals using venue-
based, convenience sampling methods. For the clinic survey, we intend
to recruit and screen 2400 HIV-positive individuals seeking HIV care at
medical clinics. A total of 1200 eligible injection drug users (age >=
18 yrs), 1200 eligible high-risk heterosexuals (age 18 to 60 yrs), and
2400 eligible HIV-positive individuals (age >= 18 yrs) will be
surveyed. CDC will collaborate with local health department staff and
outreach workers in each MSA to identify venues and clinics appropriate
for data collection. Surveys will be administered by trained, local
interviewers. There is no cost to respondents other than their time.
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
Data collection Number of Number of burden per Total burden
Target population form respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
Injection drug users.......... Community 500 1 5/60 42
Screener.
Eligible injection drug users. Community Survey 400 1 25/60 167
High-risk heterosexual Community 500 1 5/60 42
individuals. Screener.
Eligible high-risk Community Survey 400 1 25/60 167
heterosexual individuals.
HIV-positive individuals...... Clinic Screener. 933 1 5/60 78
[[Page 18555]]
Eligible HIV-positive Clinic Survey... 800 1 25/60 333
individuals.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 829
----------------------------------------------------------------------------------------------------------------
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-7886 Filed 4-1-11; 8:45 am]
BILLING CODE 4163-18-P